Literature DB >> 2020772

What have we learnt from hyperbaric oxygen?

S Dische1.   

Abstract

The 15 randomised controlled clinical trials of hyperbaric oxygen in radiotherapy yielded three with highly significant benefit and six with useful margins not reaching statistical significance. The increase in tumour control was partly negated by an increase in normal tissue effect. Now simple carbogen breathing in animal tumour models has shown high efficiency and there is the potential for its use in man as a simple means of hypoxic cell radiosensitization.

Entities:  

Mesh:

Year:  1991        PMID: 2020772     DOI: 10.1016/0167-8140(91)90191-i

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Monitoring of hemodynamic changes induced in the healthy breast through inspired gas stimuli with MR-guided diffuse optical imaging.

Authors:  C M Carpenter; R Rakow-Penner; S Jiang; B W Pogue; G H Glover; K D Paulsen
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

Review 2.  Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

Authors:  M Saunders; S Dische
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 3.  Hyperbaric oxygenation for tumour sensitisation to radiotherapy.

Authors:  Michael H Bennett; John Feldmeier; Robert Smee; Christopher Milross
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

4.  The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.

Authors:  D M Brizel; S Lin; J L Johnson; J Brooks; M W Dewhirst; C A Piantadosi
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

5.  Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

Authors:  K Ogawa; Y Yoshii; O Inoue; T Toita; A Saito; Y Kakinohana; G Adachi; S Iraha; W Tamaki; K Sugimoto; A Hyodo; S Murayama
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

6.  Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas.

Authors:  K Kohshi; Y Kinoshita; H Imada; N Kunugita; H Abe; H Terashima; N Tokui; S Uemura
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

Authors:  P J Hoskin; M I Saunders; H Phillips; H Cladd; M E Powell; K Goodchild; M R Stratford; A Rojas
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 8.  Hyperbaric oxygenation for tumour sensitisation to radiotherapy.

Authors:  Michael H Bennett; John Feldmeier; Robert Smee; Christopher Milross
Journal:  Cochrane Database Syst Rev       Date:  2018-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.